Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-011319

President, R&D sold 80,450 shares at an average $4.50 ($362,298)

  • President, R&D acquired 176,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-28 Sale : show line 1 in the form −3,220 $4.63 $14,909 516,868 D
2025-01-28 Grant or award : show line 2 in the form +176,400 693,268 D
2025-01-29 Sale : show line 3 in the form −46,407 $4.55 $211,152 646,861 D
2025-01-30 Sale : show line 4 in the form −30,823 $4.42 $136,238 616,038 D
Open-market sales · 80,450 sh · avg $4.50 · $362,298
Loading xslF345X05/ownership.xml…